Scott Shultz

Publications

178

Citations

H-Index

2007

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Scott Shultz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, natural sciences, and medicinal chemistry.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryCatalysisChemistryEngineeringHypertension

Publications per year

2007–2011

Publications

Catalytic, Enantioselective Synthesis of Taranabant, a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

Cheng‐yi Chen, Lisa Frey, Scott Shultz et al. · Organic Process Research & Development · 2007 · 80 citations

Cannabis Use, Chiral Amide 1, Medicinal Chemistry +14

Multiparallel microfluidic high-performance liquid chromatography for high-throughput normal-phase chiral analysis

Peter Sajonz, Wes Schafer, Xiaoyi Gong et al. · Journal of Chromatography A · 2007 · 52 citations

Engineering, Supercritical Fluid Chromatography, Analytical Microsystems +6

A Practical Synthesis of Renin Inhibitor MK-1597 (ACT-178882) via Catalytic Enantioselective Hydrogenation and Epimerization of Piperidine Intermediate

Carmela Molinaro, Scott Shultz, Amélie Roy et al. · The Journal of Organic Chemistry · 2011 · 34 citations

Hypertension, Bioorganic Chemistry, Chemistry +19

Rapid Analytical Method Development Using Multiparallel Microfluidic High-Performance Liquid Chromatography in Support of Pharmaceutical Process Research

Peter Sajonz, Wes Schafer, William R. Leonard et al. · Journal of Liquid Chromatography & Related Technologies · 2008 · 12 citations

Rows per page

1–4 of 4